Wenger Vieli advised the lead investor Redalpine Opportunity Fund on the deal. Car subscription pioneer Carvolution has successfully closed a new financing round to further strengthen...
Carvolution’s CHF 16.2 Million Series D Financing Round
CONET Technologies’ Acquisition of Emineo Group
Wenger Vieli and Renzenbrink & Partner advised CONET Technologies on the deal. CONET Technologies, a portfolio company of IK Partners, announced the acquisition of emineo, a Swiss...
Candi Solar’s Series B Financing Round
Wenger Vieli advised the French impact fund STOA Infra & Energy on the deal. The French impact fund STOA Infra & Energy led the Series B financing...
VINCI Energies SA’s Acquisition of Parts of Kontron Group IT Business
Schoenherr, Loloci & Partners, Pinsent Masons LLP and Wenger Vieli AG advised Kontron AG on the deal, Baker & McKenzie advised VINCI Energies. Kontron AG (formerly...
F10’s Funding Round And Management Buy-In
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
F10’s Funding Round And Management Buy-In
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
Avery Dennison’s Acquisition of TexTrace
Wenger Vieli advised Jakob Müller Holding AG on this transaction. Jakob Müller Holding, a leading Swiss OEM for the textile industry, has sold TexTrace AG, a...
Unigestion’s Acquisition of Home Instead
Homburger advised Credit Suisse (Switzerland) Ltd. in connection with the financing of the acquisition. Bär & Karrer acted as legal advisor to the sellers in this...
Klingel Medical Metal’s Acquisition of Ruetschi Group
Renzenbrink & Partner, Wenger Vieli and Milbank advised Klingel medical metal on the deal. Bär & Karrer acted as legal advisor to the sellers in this...
Atlas Antibodies’ Acquisition of Evitria Group
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...